Impinj, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Chris Diorio
- Full Time Employees
- 457
- Sector
- Technology
- Industry
- Semiconductors
- Address
- 400 Fairview Avenue North Seattle WA United States of America 98109
- IPO Date
- Jul 21, 2016
- CIK
- 0001114995
- Website
- impinj.com
- Similar Companies
- Business
- Impinj, Inc. (NASDAQ: PI) develops and sells RAIN RFID solutions that connect billions of everyday items to cloud-based applications, enabling real-time tracking, inventory management, and authentication for the Internet of Things; core products include endpoint integrated circuits (ICs) such as Monza tag chips for item identification, reader ICs for embedded read/write capabilities, Speedway and R-series readers in fixed, handheld, and gateway form factors for interrogating tags, and software platforms like ItemSense for data management, analytics, and integration with enterprise systems. The company, founded in 2000 and headquartered in Seattle, Washington, operates globally across the Americas, Europe, Asia-Pacific, Middle East, and Africa, serving industries including retail, supply chain and logistics, healthcare, manufacturing, and transportation through a network of partners offering complementary printers, inlays, and modules. Recent developments include the expansion of its Gen2X protocol in November 2025 to M770/M780 ICs with features like Endpoint IC Verification and Tag Selection for enhanced enterprise performance in dense environments; a September 2025 offering of $170 million in 0% convertible senior notes due 2029 to bolster financial resources; appointment of a Senior Vice President of SaaS and Cloud Services to drive recurring software revenue; and positive cash flow of $18 million in Q3 2025 alongside a strengthened balance sheet of $265.1 million in cash equivalents and investments.
Company News
Berger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (NASDAQ: ADMA)
Impinj (PI) Just Overtook the 20-Day Moving Average
Impinj Set To Revolutionize Logistics With Tracking Chips. CEO Eyes 'Gigantic Opportunity.
Should You Buy Impinj (PI) After Golden Cross?
California State Teachers Retirement System Increases Position in Impinj, Inc. $PI
Impinj, Inc. (PI) Q2 2026 Earnings Call Transcript
Impinj Q2 Earnings Call Highlights
Impinj (PI) Tops Q2 Earnings and Revenue Estimates
Impinj Reports Second Quarter 2026 Financial Results
Impinj, Inc. $PI Shares Acquired by Fifth Third Bancorp
What's going on with Seattle startup funding, a Kalshi setback, Impinj's long game, and a smartphone detox
The little chips that could: How Impinj has survived 26 years in a market that's ‘just getting going'
Impinj to Announce Second-Quarter 2026 Financial Results
Director Sells 33,000 Impinj Shares Worth $4.6 Million
Director Sells 45,000 Impinj Shares Worth $6.4 Million
Intel vs. Impinj: Which Technology Stock Is a Better Buy in 2026?
Insiders Are Selling These 3 Stocks—Should Investors Be Concerned?
New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myel
Large Impinj Investor Trims Position by $11.3 Million
Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review